Calls
29
#1013
Alpha Score 20.6
BarbarianCap
Twitter Analyst
Win Rate
53.6%
return
-1.6%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Mar 01
$483.75
-17.9%
The author suggests gold is poised for a significant price increase, as even a marginal 1 basis point rise in currently tiny allocations would result in a 1.5% price appreciation.
The author suggests gold is poised for a significant price increase, as even a marginal 1 basis point rise in currently tiny allocations would result in a 1.5% price appreciation.
Commodities
Long
Feb 14
$54.35
+19.3%
The author reiterates a long-held thesis that the failure of the EV/ESG narrative will be a long-term tailwind for the traditional energy sector.
The author reiterates a long-held thesis that the failure of the EV/ESG narrative will be a long-term tailwind for the traditional energy sector.
Thematic ETFs
Long
Feb 14
$224.23
-16.1%
The consulting sector is poised for growth driven by increasing corporate demand for generative AI implementation, as evidenced by Capgemini's forward-looking guidance.
The consulting sector is poised for growth driven by increasing corporate demand for generative AI implementation, as evidenced by Capgemini's forward-looking guidance.
AI Software
Long
Feb 12
$96.20
+20.1%
The author believes the pre-market price action signals a bottom and a trend reversal, suggesting the stock is poised to move higher.
The author believes the pre-market price action signals a bottom and a trend reversal, suggesting the stock is poised to move higher.
Retail & Mobility
Long
Aug 09
$245.89
+5.6%
Buy ABBV as Lupron, used in fertility protocols, stands to benefit from increased public attention on fertility treatments driven by AOC's egg-freezing news; very thin catalyst.
Pharma & Biotech
Long
Aug 09
$46.21
-6.0%
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
Pharma & Biotech
Long
Aug 09
$33.38
-3.1%
Buy Merck KGaA (MKKGY) as its Gonal-f fertility drug benefits from heightened public awareness around egg freezing following AOC's announcement; thin catalyst but author flags it as a positive.
Banks
Long
Aug 09
$13.60
+0.1%
Buy OGN as AOC's public egg-freezing announcement raises fertility treatment visibility; Follistim is a key fertility drug and OGN is in acquisition process, giving a near-term catalyst overlay.
Pharma & Biotech
Long
Aug 09
$28.20
-9.0%
Buy PGNY as the leading fertility benefits platform; AOC's public egg-freezing announcement may accelerate employer and employee interest in fertility benefit coverage, directly benefiting PGNY's core business.
Healthcare Services
Long
Aug 09
$89.95
-5.8%
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
Pharma & Biotech
Long
Aug 09
$35.34
+2.4%
Buy generic drug makers TEVA, Sandoz (SDZNY), and Hikma (HKMPY) as fertility drug generics see potential demand uplift from increased public awareness around egg freezing; speculative thematic call.
Pharma & Biotech
Long
Jul 31
$42.53
-6.1%
Buy Brookfield Asset Management given its direct ownership of Westinghouse Electric, whose confidential IPO filing is a value-unlocking catalyst that could surface significant embedded value in BN's portfolio.
Buy Brookfield Asset Management given its direct ownership of Westinghouse Electric, whose confidential IPO filing is a value-unlocking catalyst that could surface significant embedded value in BN's portfolio.
Capital Markets
Long
Jul 31
$86.00
+12.0%
Buy Cameco as a direct uranium/nuclear fuel beneficiary of the nuclear renaissance theme, with the Westinghouse IPO filing serving as a concrete catalyst validating renewed institutional interest in nuclear power infrastructure.
Buy Cameco as a direct uranium/nuclear fuel beneficiary of the nuclear renaissance theme, with the Westinghouse IPO filing serving as a concrete catalyst validating renewed institutional interest in nuclear power infrastructure.
Critical Minerals
Long
May 12
$21.88
+14.2%
Structural phosphate supply deficit drives fertilizer prices higher, benefiting Mosaic as a key producer with reduced spending and guidance withdrawal.
Structural phosphate supply deficit drives fertilizer prices higher, benefiting Mosaic as a key producer with reduced spending and guidance withdrawal.
Chemicals
Showing 15 of 29 calls · sorted by mentions
Choose a mentions count to open ticker posts.
BarbarianCap has 29 trade ideas tracked on Buzzberg across 29 tickers since February 2026. Win rate 54% across 28 evaluated calls, average return -1.6%. Ranked #1013 on the Buzzberg Alpha leaderboard. Most covered: GOLD, CROX, XLE.
